Your browser doesn't support javascript.
loading
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for ß-Thalassemia Patients.
Saad, Hanan Kamel M; Abd Rahman, Alawiyah Awang; Ab Ghani, Azly Sumanty; Taib, Wan Rohani Wan; Ismail, Imilia; Johan, Muhammad Farid; Al-Wajeeh, Abdullah Saleh; Al-Jamal, Hamid Ali Nagi.
Afiliação
  • Saad HKM; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Nerus 21300, Terengganu, Malaysia.
  • Abd Rahman AA; Pathology Department, Hospital Sultanah Nur Zahirah, Kuala Terengganu 20400, Terengganu, Malaysia.
  • Ab Ghani AS; Pathology Department, Hospital Sultanah Nur Zahirah, Kuala Terengganu 20400, Terengganu, Malaysia.
  • Taib WRW; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Nerus 21300, Terengganu, Malaysia.
  • Ismail I; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Nerus 21300, Terengganu, Malaysia.
  • Johan MF; Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelatan, Malaysia.
  • Al-Wajeeh AS; Anti-Doping Lab Qatar, Doha 27775, Qatar.
  • Al-Jamal HAN; School of Biomedicine, Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kuala Nerus 21300, Terengganu, Malaysia.
Biomedicines ; 10(1)2022 Jan 17.
Article em En | MEDLINE | ID: mdl-35052868

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article